On October 23, Check Point rose 5.45% in Regular Trading, trading at 151.25 USD/share, with turnover of 111 million USD.
The clearest recent catalyst was an October 15 analyst update in which UBS raised its price target on Check Point to 145 dollars from 135 dollars while maintaining a Neutral rating.
Supporting context came from the company’s July quarterly report: non-GAAP EPS was 2.55 dollars, above the 2.45 dollars expected by analysts, while revenue was 673.6 million dollars, slightly below consensus. Management also maintained full-year guidance for revenue of 2.77 billion to 2.85 billion dollars and non-GAAP EPS of 10.05 dollars to 10.85 dollars. Recent commentary has still pointed to near-term growth pressure tied to go-to-market adjustments, but the target-price increase and earnings resilience appear to have supported the shares.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments